89. リンパ脈管筋腫症 [臨床試験数:38,薬物数:42(DrugBank:19),標的遺伝子数:26,標的パスウェイ数:134

Searched query = "Lymphangioleiomyomatosis", "LAM"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03062943October 20167/10/2016A Study of Nintedanib for LymphAngioleioMyomatosis (LAM)A Pilot Study of Nintedanib for LymphAngioleioMyomatosis (LAM)LymphangioleiomyomatosisDrug: NintedanibIRCCS MultimedicaNULLRecruiting18 YearsN/AFemale30Phase 2Italy
2EUCTR2015-004919-20-IT09/03/201611/08/2016A pilot study of nintedanib for lymphangioleiomyomatosis (LAM)A pilot study of nintedanib for lymphangioleiomyomatosis (LAM) - A pilot study of nintedanib for lymphangioleiomyomatosis (LAM) Female subjects affected by Llymphangioleiomyomatosis (LAM)
MedDRA version: 19.0Level: PTClassification code 10049459Term: LymphangioleiomyomatosisSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
Trade Name: OfevMULTIMEDICA S.P.A.NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: no
30Phase 3Italy